MUCOCUTANEOUS PARANEOPLASTIC MANIFESTATIONS OF HEMATOLOGIC MALIGNANCIES

被引:58
作者
KURZROCK, R
COHEN, PR
机构
[1] UNIV TEXAS, MD ANDERSON CANC CTR, DEPT MED SPECIALTIES, DERMATOL SECT, HOUSTON, TX 77030 USA
[2] UNIV TEXAS, SCH MED, DEPT DERMATOL, HOUSTON, TX USA
[3] UNIV TEXAS, SCH MED, DEPT PATHOL, HOUSTON, TX 77030 USA
关键词
D O I
10.1016/S0002-9343(99)80141-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: TO review the clinical manifestations, pathophysiology, and oncologic implications of the major mucocutaneous paraneoplastic syndromes that can appear in patients with hematologic malignancies. METHODS: A comprehensive search of the medical literature was conducted. RESULTS: In vesiculobullous conditions, although the primary lesions are blisters, observed abnormalities may include large, flaccid bullae (pemphigus vulgaris), superficial crusted erosions (pemphigus foliaceus), or erythema multiforme-like lesions (paraneoplastic pemphigus). Paraneoplastic neutrophilic dermatoses include Sweet's syndrome and pyoderma gangrenosum. In both of these conditions, the skin lesions are characterized by a dermal infiltrate of mature neutrophils. Vascular dermatoses include vasculitis and erythromelagia. Papulosquamous conditions are characterized by small (papules) or large (plaques) raised skin lesions and are usually associated with solid tumors. Amyloidosis is a malignancy-related condition that probably stems from immune dysregulation. RECOMMENDATIONS: Continued surveillance of patients with potential cutaneous paraneoplastic syndromes is necessary, since the malignancy may not be immediately detectable. Some of the cutaneous paraneoplastic syndromes will respond to specific measures, such as systemic corticosteroid therapy, but for the most part, successful resolution requires eradication of the underlying malignancy.
引用
收藏
页码:207 / 216
页数:10
相关论文
共 51 条
[1]   PARA-NEOPLASTIC SYNDROMES - A WINDOW ON THE BIOLOGY OF CANCER [J].
ABELOFF, MD .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (25) :1598-1600
[2]   PARANEOPLASTIC PEMPHIGUS - AN AUTOIMMUNE MUCOCUTANEOUS DISEASE ASSOCIATED WITH NEOPLASIA [J].
ANHALT, GJ ;
KIM, S ;
STANLEY, JR ;
KORMAN, NJ ;
JABS, DA ;
KORY, M ;
IZUMI, H ;
RATRIE, H ;
MUTASIM, D ;
ARISSABDO, L ;
LABIB, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (25) :1729-1735
[3]   POSSIBLE DRUG-INDUCED PEMPHIGUS-LIKE ANTIBODIES WITH THE CLINICAL MANIFESTATION OF ERYTHEMA MULTIFORME [J].
ANSEL, J ;
PETROZZI, JW ;
KUMAR, V .
ARCHIVES OF DERMATOLOGY, 1983, 119 (12) :1006-1009
[4]   METABOLIC EFFECTS OF AN INSULIN-LIKE FACTOR CAUSING HYPOGLYCEMIA IN A PATIENT WITH A HEMANGIOPERICYTOMA [J].
BENN, JJ ;
FIRTH, RGR ;
SONKSEN, PH .
CLINICAL ENDOCRINOLOGY, 1990, 32 (06) :769-780
[5]  
BEUTNER EH, 1964, P SOC EXP BIOL MED, V117, P505
[6]  
BUREAU Y., 1963, LAVAL MED, V34, P642
[7]   PARANEOPLASTIC PEMPHIGUS IS A DISTINCT NEOPLASIA-INDUCED AUTOIMMUNE-DISEASE [J].
CAMISA, C ;
HELM, TN .
ARCHIVES OF DERMATOLOGY, 1993, 129 (07) :883-886
[8]  
CHRISTY NP, 1961, LANCET, V1, P85
[9]   THE SIGN OF LESER-TRELAT IN ASSOCIATION WITH SEZARY-SYNDROME - SIMULTANEOUS DISAPPEARANCE OF SEBORRHEIC KERATOSES AND MALIGNANT T-CELL CLONE DURING COMBINED THERAPY WITH PHOTOPHERESIS AND INTERFERON-ALFA [J].
COHEN, JH ;
LESSIN, SR ;
VOWELS, BR ;
BENOIT, B ;
WITMER, WK ;
ROOK, AH .
ARCHIVES OF DERMATOLOGY, 1993, 129 (09) :1213-1215
[10]   SWEETS SYNDROME AND MALIGNANCY [J].
COHEN, PR ;
KURZROCK, R .
AMERICAN JOURNAL OF MEDICINE, 1987, 82 (06) :1220-1226